Overall, Nfl levels in the blood indicate the underlying clinical burden of familial FTD and demonstrate the potential for differentiating genetic subtypes, particularly with high sensitivity and predictive value in GRN mutation carriers. The gene discussed is GRN; the disease is frontotemporal dementia.